This war "epidemic", I am!
Release time:
2020-07-15
Donations Donations Guaranteed Supply
Spike Help New Crown Epidemic Prevention and Control
On February 11, Spike Pharmaceutical Company, through the Red Cross Society of Jinhua City, directed to Jinhua City Central Hospital donated 200000 yuan in cash and 100 barrels of 75% unilateral ethanol disinfectant for the hospital's new crown pneumonia epidemic prevention and control needs. This is the fourth special donation made by Jianfeng Group and its subsidiaries since the outbreak of the epidemic.
The new coronary pneumonia epidemic was first discovered in Wuhan, showing a fast spread, wide range of impact, extremely harmful characteristics, as the outbreak coincides with the Spring Festival, the dense flow of people to create conditions for the spread of the virus, but also to the epidemic prevention and control work around the pressure. Medical institutions in most provinces across the country are in urgent need of protective materials, and there is also a market shortage of alcohol, masks and other ordinary daily health protective products.
On January 25, the first day of the Lunar New Year, entrusted by the group company, daye peak cement company donated 1 million yuan to daye municipal government to purchase medical materials for the prevention and control of the new coronary pneumonia epidemic. On February 1, Yunnan Jianfeng Cement Company donated a batch of protective masks to the government of Liushun Town, Simao District, Pu 'er City, and went to the local prevention and control card point to comfort the staff. February 2, shanghai Beika Pharmaceutical Technology Co., Ltd., a subsidiary of Jianfeng, donated cash 300000 yuan and 200 sets of protective clothing, 100 pairs of canvas gloves and 2000 medical masks to the Red Cross Society of Dongzhi County, Anhui Province. To the peak pharmaceutical to Jinhua Central Hospital targeted donation, the peak group and its subsidiaries have donated cash and materials worth more than 1.5 million yuan for the prevention and control of the epidemic.
In addition to targeted donations to medical institutions, the peak man has also done a lot of work for the daily prevention and control of the epidemic in Jinhua City. At the beginning of the outbreak, the majority of employees of Peak Pharmaceuticals and its subordinate Jinhua Pharmaceutical Company and Peak Pharmacy gave up rest and organized the purchase of masks, alcohol, thermal guns, disinfectants, protective clothing and other epidemic prevention supplies through various channels. According to incomplete statistics, since the outbreak of the epidemic, the medical material circulation enterprises under the peak have organized the deployment of more than 64000 masks, more than 300 warm guns, more than 200,000 pairs of disposable medical gloves, and various epidemic prevention supplies such as disinfection nights and protective clothing. In addition to supplying citizens, they have also assisted the government in storing epidemic prevention drugs and cooperated with Jinhua Economic and Information Bureau in requisitioning epidemic prevention supplies.
Group Chairman Jiang Xiaomeng said that the epidemic is ruthless, the peak has love, the current new crown epidemic needs the people of the whole country to work together to overcome the difficulties, the peak as a well-known listed company, has the responsibility to contribute to the prevention and control of the epidemic. "I believe that if we unite as one and cheer together, we will surely win this battle without gunpowder smoke!"
Implement the responsibility and take more measures
to do a good job in internal epidemic prevention and control
The epidemic prevention and control work within Jianfeng Group started as early as around New Year's Day. Since the online media disclosed the news of the occurrence of viral pneumonia infectious diseases in Wuhan, it has attracted great attention from the leaders of the group, and early reminded the Daye Jianfeng Cement Company adjacent to Wuhan to pay attention to relevant information and implement preventive measures in a timely manner. Before the relevant departments have officially released the epidemic information, Daye Peak has formulated the epidemic prevention and control plan according to the 2003 SARS epidemic prevention standard, strengthened internal sanitation, disinfection and other work, and put forward epidemic prevention requirements for all employees, especially the sales staff in Wuhan area and Wuhan employees. With the development of the epidemic, prevention and control measures have been adjusted and implemented accordingly to ensure the stability of the production organization and the state of mind of employees.
Due to the intensive movement of people during the Spring Festival, the Group has been paying great attention to the development of the epidemic and making predictions accordingly. After learning the information that the epidemic has spread outside Hubei Province, on January 21, the company successively issued the "Notice on Prevention of Novel Coronavirus Pneumonia" and "Supplementary Notice on Prevention of Novel Coronavirus Pneumonia" to make arrangements for epidemic prevention during the Spring Festival and remind employees of the problems that should be paid attention to during the holidays. The Group set up a leading group for the prevention and control of the new coronavirus epidemic, headed by Chairman Jiang Xiaomeng, and the leading groups for the prevention and control of the epidemic and the working groups for personnel control, isolation and treatment, environmental disinfection and material security of the subordinate enterprises were also set up to divide the work and implement the responsibilities. Starting from January 28, every day, the company's employees' trends during the Spring Festival, contacts and other relevant information, timely summary, investigation of possible hidden dangers of the epidemic, to ensure that if there is a situation can be found in time, effective disposal, to achieve "early discovery, early reporting, early isolation, early treatment".
According to the development of the epidemic situation, on the third day of the new year on January 27, the group company held an emergency meeting on the prevention and control of the epidemic situation. After the meeting, the "Notice of Jianfeng Group on Preventing Novel Coronavirus Pneumonia (No. 2)" was issued to make further requirements for the adjustment and implementation of epidemic prevention and control measures, and to adjust the holiday time in time according to relevant government regulations. On February 3, the Group held a special conference call with the participation of the heads of the subordinate enterprises to put forward requirements for the prevention and control of the epidemic.
During the Spring Festival holiday, epidemic prevention and control staff at all levels kept in close contact with the epidemic prevention and control leading group of the group company, communicated the requirements of the group's epidemic prevention and control work in a timely manner through the "group epidemic prevention and control" WeChat group, exchanged epidemic information, prevention and control work of various enterprises and personnel trends, and disseminated epidemic prevention and control knowledge such as the "novel coronavirus infection pneumonia prevention manual" and "and" and "in the unit canteen; each enterprise also conveys the company's relevant requirements and health and epidemic prevention knowledge to every employee through QQ, WeChat, mobile phone short messages, publicity boards and other forms according to their actual conditions. Each enterprise has formulated a scientific and orderly prevention and control plan and emergency plan for the new coronary pneumonia epidemic situation for the resumption of work and production, from the control of people flow and traffic flow to the distribution of epidemic prevention materials, from disinfection of public areas to time-sharing of meals for employees, from the investigation of the hidden dangers of the epidemic to the dynamic management of the health status of employees, detailed and specific provisions have been made to lay a good foundation for the resumption of work and production.
On January 31, Chairman Jiang Xiaomeng, General Manager Yu Jianhong, and Deputy General Manager Xiang Chongping of the Group Company went to the Peak Pharmacy to express their condolences to the employees who worked overtime during the Spring Festival and fought on the front line of the epidemic, checked and implemented the epidemic prevention and control work, and deployed the next step in the epidemic prevention and control work. After the resumption of work on February 10, the leaders of the group company also went deep into the grass-roots enterprises to inspect and guide the epidemic prevention and control work, understand the resumption of work, condolences to front-line employees, further implement the epidemic prevention and control work, to ensure that the enterprise can operate safely.
Work together to prevent death
Enterprises have resumed work in an orderly manner
With the end of the Spring Festival holiday approaching, how to do a good job in the prevention and control of the epidemic at the same time to do a good job of enterprises to resume work and production, is an urgent need for enterprises to solve the problem. Among the enterprises under the Sharp Peak Group, whether in Jinhua or in other provinces, they have received support and help from the government management department where the enterprise is located, and the relevant person in charge has visited the enterprise site many times to investigate and understand the enterprise's epidemic prevention and control and preparations for the resumption of work.
The Jindong District Government also made a special case to allow the Jianfeng International Trade Warehouse to unload the wingers at the station, thus reducing the loss of goods stranded. On January 30, members of Guizhou Huangping peak management team bid farewell to their families and went to work; on February 1, a group of management backbones of Yunnan peak also returned to the enterprise; on February 9, the "peak retrograde"-Daye peak Jinhua management backbones set out to return to Hubei, further comprehensive arrangements for the implementation of epidemic prevention and control and resumption of work.
Doing a good job of epidemic prevention and control is a prerequisite for the resumption of work. As the main body of the resumption of work, as early as during the Spring Festival holiday, after the state, province and city made relevant regulations and requirements for the resumption of work, the group company began to make relevant preparations, according to the actual situation of each enterprise, to find out the whereabouts and contacts of employees during the holiday, and to investigate the hidden dangers of the epidemic. Issued "Notice on Resuming Work after the Spring Festival in 2020" and "Matters needing attention for resuming work after the Spring Festival in 2020". Through various channels to every employee; organize employees to seriously study epidemic prevention knowledge, epidemic prevention and control during the matters needing attention and other resumption of training materials, for the resumption of work after the production, epidemic prevention and control of both hands to do a good job in the early preparation. On February 7, the Group held a special conference call to arrange for the resumption of work to make arrangements for production and epidemic prevention after the resumption of work. In accordance with the territorial government's requirements for resumption of work, each enterprise prepares relevant information and applies for resumption of work. Due to the full preparation, to do the measures in place, personnel in place, responsibility in place, the resumption of work required epidemic prevention supplies in place, Jianfeng Group headquarters by the Wucheng District Party Committee and government included in the first batch of 47 resumption of work enterprises list, peak pharmaceutical industry is also listed as the first approval of the development zone enterprises.
At present, the headquarters of the group company and Jianfeng Pharmaceutical Co., Ltd. resumed work on February 10, Jianfeng Health Technology Co., Ltd. resumed work on February 11, and Cable Co., Ltd. resumed work on February 13. The application for resumption of work by Jianfeng International Trade Company and Jinhua Pharmaceutical Company has been approved. Peak Pharmacy has been working normally during the Spring Festival because it undertakes the task of purchasing and selling epidemic prevention materials. Among foreign enterprises, Hubei Province requires that construction is not allowed before February 20, daye peak directly affected, Guizhou Huangping peak, Anhui Zhongwang Pharmaceutical's application for resumption of work has been approved by the management department, Yunnan peak production is normal, Tianjin enterprises are going through the approval procedures for resumption of work.
From the resumption of work at the Group's headquarters on February 10, the Group's leaders went separately to various subsidiaries in Jinhua to carefully understand the implementation of epidemic prevention and control measures and preparations for the resumption of work. At present, while doing a good job in the management requirements for Jinhua enterprises to resume work, enterprises have further strengthened epidemic safety warnings, posting epidemic risk notification cards in office areas and key areas of the factory to ensure that each employee can clearly understand relevant prevention and control measures and improve their epidemic protection ability. Sign an epidemic prevention commitment with subordinate enterprises and each employee to strengthen the prevention and control awareness of all employees. Every day, the body temperature of all employees to and from work, the work area personnel into the management and information registration, employee health dynamic information daily, regular distribution of protective equipment, public areas twice a day of comprehensive disinfection ...... become the "compulsory course" of the enterprise management department ". Due to the requirements of epidemic prevention and control, the current enterprises are only part of the resumption of work, there are varying degrees of staff to the post rate is insufficient, can not meet the normal production needs and other issues, each enterprise according to their own situation, to carry out comprehensive equipment maintenance, technical transformation, and constantly check the leak to fill the gap, for the upcoming full resumption of work to make full preparations.
Since the outbreak of the new coronary pneumonia epidemic, the sharp peak group attaches great importance to, from the group headquarters to the subordinate enterprises, are actively organizing the implementation of the epidemic prevention and control work, multi-measures, effectively protect the life safety and health of all the company's cadres and employees. So far, no cases of new crown pneumonia have been found in the whole group, and the state of mind of employees is stable. (Fu Yiwu Ni Yingzhen Fonz)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31